Personalized Medicine is often
defined as “the right treatment for the right person at the right time.”
Personalized medicine is becoming the place to be in clinical diagnostics as
well and slowly becoming the reality of future in the diagnostics industry
By Technology Segment - Personalized
Medicine diagnostics market is expected to grow with a double digit CAGR for
the period of 2013 to 2018. It is expected that personalized medicine
diagnostics market by technology is going to double by 2018 from its current
market size in 2012. In this segment, Point of Care Testing and Molecular
Diagnostics segments control the #1 and #2 positions in 2012.
By Diseases Segment - Personalized
Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018.
Diabetes management test and Cancer management test are the leading market in
this segment.
Renub Research report entitled
“Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine
Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and
Other Testing)” report provides a comprehensive analysis of the emerging
personalized medicine diagnostic market segments, including their dynamics,
size, market share, key investors, clinical trials statement, technological
trends, company analysis and a realistic future potential for personalized
medicine in clinical testing. The report also entails major drivers and
challenges of personalized medicine diagnostic market. This 173 page report
contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics
Market.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-market-and-forecast
Personalized Medicine Diagnostics
(Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders,
Tumor Markers, Molecular Blood Typing and Other Testing) contains 12 chapters
Chapter 1 is Executive Summary
Chapter 2 contains worldwide
personalized medicine diagnostic market & forecast (2011 – 2018). The
market includes technological & disease-wise personalized medicine
diagnostics market
Chapter 3 contains worldwide
personalized medicine diagnostic market share segment. Segment include
Technology, Disease-Wise
Chapter 4 contains segment-wise
technological personalized diagnostic market & forecast (2010 - 2018)
Chapter 5 contains geographical
segment-wise personalized diagnostic market & forecast (2011 - 2018)
Chapter 6 contains disease-wise
personalized diagnostic market share & forecast (2011 - 2018)
Chapter 7 contains disease-wise
personalized diagnostic market & forecast (2011 - 2018)
Chapter 8 and 9 contains clinical
trial statement and key investors in Personalized Diagnostics Medicine Market
Chapter 10 and 11 contains growth
Drivers & Challenges for Personalized Medicine
Chapter 12 contains company analysis
of Personalized Medicine
Companies analyzed in this report
are:
- HistoRx
- A&G Pharmaceuticals Inc
- 20/20 GeneSystems
- Tethys Bioscience
- Genomas Inc
To Buy The Copy of
This Report Visit: http://www.marketresearchreports.biz/analysis/170291
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment